
Navamedic Investor Relations Material
Latest events

M&A Announcement
Navamedic
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Navamedic
Access all reports
Navamedic ASA is a Norwegian pharmaceutical company focused on developing, producing, marketing, and distributing a range of healthcare products. Its portfolio includes both prescription and non-prescription pharmaceuticals, medical nutrition products, medical devices, and consumer health items such as food supplements and cosmetics. The company primarily serves hospitals, pharmacies, and patients across the Nordic countries, Benelux, and the Baltics, with additional presence in the UK and other European markets. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange.
Key slides for Navamedic


Q4 2024
Navamedic


M&A Announcement
Navamedic
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
NAVA
Country
🇳🇴 Norway